Oxygent as a top load to colloid and hyperoxia is more effective in resuscitation from hemorrhagic shock than colloid and hyperoxia alone.
Perfluorocarbon (PFC) emulsions are intravascular oxygen therapeutics that temporarily enhance tissue oxygenation in dilutional anemia. However, PFC emulsions are not resuscitation fluids because PFCs only work optimally in the presence of high O2 partial pressure (hyperoxia); moreover, because they have no oncotic potential, dosing limitations prevent their use to permanently replace large hemorrhage volumes. Our objective was to clarify whether in the presence of hyperoxia a conventional colloid therapy supplemented by PFC is more efficacious than colloid alone. To answer this question, 22 anesthetized, ventilated dogs were hemorrhaged to a mean arterial pressure of 45 mmHg and were kept at this level until a metabolic O2 debt of 120 mL kg(-1) body weight had evolved. Hyperoxia was established and dogs were randomly allocated to receive colloid (6% HES, Hydroxy Ethyl Starch shed blood volume) or colloid together with Oxygent (perflubron emulsion, 60%, w/v; Alliance Pharmaceutical Corp., San Diego, CA; single dose, 4.5 mL kg(-1); i.e., 2.7 g PFC kg body weight) in a blinded fashion. Hemodynamic and O2 transport parameters, intestinal mucosal blood flow (microspheres), and O2 partial pressure (MDO-Electrode; Eschweiler, Kiel, Germany) were measured at baseline, in shock, and during 3 h post-therapy. In the presence of hyperoxia, Oxygent improved the amount of physically dissolved O2 in plasma and increased the contribution of physically dissolved O2 to global O2 delivery (P < 0.05) and thus whole body O2 consumption when compared with colloid alone (P < 0.05). As a result, Oxygent reduced intestinal mucosal hypoxia and global O2 debt within the first hour post-therapy (P < 0.05). We conclude that under hyperoxic conditions, fluid resuscitation supplemented by Oxygent was more efficacious than colloid and hyperoxia alone. PFC temporarily enhanced intestinal mucosal tissue oxygenation during resuscitation.
Kemming
Gregor I
GI
Institute for Surgical Research, Klinikum Grosshadern, Ludwig-Maximilians-University Munich, 81377, Germany.
Meisner
Franz G
FG
Wojtczyk
Christoph J
CJ
Packert
Kristian B
KB
Minor
Thomas
T
Thiel
Manfred
M
Tillmanns
Jochen
J
Meier
Jens
J
Bottino
Daniel
D
Keipert
Peter E
PE
Faithfull
Simon
S
Habler
Oliver P
OP
D000818:Animals; D001835:Body Weight; D003102:Colloids / Q000737:chemistry*; D003287:Contrast Media / Q000494:pharmacology; D004285:Dogs; D005466:Fluorocarbons / Q000737:chemistry / Q000494:pharmacology*; D006400:Hematocrit; D006439:Hemodynamics; D006470:Hemorrhage; D006842:Hydrocarbons, Brominated; D006895:Hydroxyethyl Starch Derivatives / Q000737:chemistry; D019271:Hypoxanthine / Q000737:chemistry; D000860:Hypoxia / Q000473:pathology*; D007413:Intestinal Mucosa / Q000473:pathology; D010100:Oxygen / Q000378:metabolism; D010101:Oxygen Consumption; D010477:Perfusion; D012771:Shock, Hemorrhagic / Q000473:pathology / Q000628:therapy* / Q000662:veterinary; D013154:Spleen / Q000166:cytology / Q000473:pathology; D013997:Time Factors; D019820:Xanthine / Q000737:chemistry
D003102:Colloids; D003287:Contrast Media; D005466:Fluorocarbons; D006842:Hydrocarbons, Brominated; D006895:Hydroxyethyl Starch Derivatives; D019820:Xanthine; D019271:Hypoxanthine; C003072:perflubron; D010100:Oxygen